Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia - PubMed (original) (raw)
Affiliations
- PMID: 1457280
Review
Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia
R M Silver. Curr Opin Rheumatol. 1992 Dec.
Abstract
The eosinophilia-myalgia syndrome, which is associated with the ingestion of L-tryptophan that contained products, occurred as an epidemic in the United States in 1989. Eosinophilia-myalgia syndrome is similar in many ways to the toxic-oil syndrome, which occurred in Spain in 1981, and to diffuse fasciitis with eosinophilia, which has been noted since 1974 to occur sporadically. Recent studies have clarified the epidemiology, histopathology, and clinical features of eosinophilia-myalgia syndrome. These studies are reviewed, and comparisons to the related syndromes, toxic-oil syndrome and diffuse fasciitis with eosinophilia, are made.
Similar articles
- Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Bolster MB, Silver RM. Bolster MB, et al. Curr Opin Rheumatol. 1994 Nov;6(6):642-9. doi: 10.1097/00002281-199411000-00016. Curr Opin Rheumatol. 1994. PMID: 7865387 Review. - Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Silver RM. Silver RM. Curr Opin Rheumatol. 1993 Nov;5(6):802-8. doi: 10.1097/00002281-199305060-00016. Curr Opin Rheumatol. 1993. PMID: 8117543 Review. - The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels.
Hertzman PA. Hertzman PA. Adv Exp Med Biol. 1996;398:339-42. doi: 10.1007/978-1-4613-0381-7_52. Adv Exp Med Biol. 1996. PMID: 8906286 Review. No abstract available. - Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Kaufman LD, Krupp LB. Kaufman LD, et al. Curr Opin Rheumatol. 1995 Nov;7(6):560-7. doi: 10.1097/00002281-199511000-00016. Curr Opin Rheumatol. 1995. PMID: 8579979 Review. - AHR activation by tryptophan--pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome?
Rieber N, Belohradsky BH. Rieber N, et al. Immunol Lett. 2010 Feb 16;128(2):154-5. doi: 10.1016/j.imlet.2009.11.008. Epub 2009 Nov 24. Immunol Lett. 2010. PMID: 19941898
Cited by
- Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.
Valent P, Degenfeld-Schonburg L, Sadovnik I, Horny HP, Arock M, Simon HU, Reiter A, Bochner BS. Valent P, et al. Semin Immunopathol. 2021 Jun;43(3):423-438. doi: 10.1007/s00281-021-00863-y. Epub 2021 May 30. Semin Immunopathol. 2021. PMID: 34052871 Free PMC article. Review. - ICON: Eosinophil Disorders.
Valent P, Klion AD, Rosenwasser LJ, Arock M, Bochner BS, Butterfield JH, Gotlib J, Haferlach T, Hellmann A, Horny HP, Leiferman KM, Metzgeroth G, Matsumoto K, Reiter A, Roufosse F, Rothenberg ME, Simon HU, Sotlar K, Vandenberghe P, Weller PF, Gleich GJ. Valent P, et al. World Allergy Organ J. 2012 Dec;5(12):174-81. doi: 10.1097/WOX.0b013e31827f4192. World Allergy Organ J. 2012. PMID: 23282419 Free PMC article. No abstract available. - Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.
Valent P, Gleich GJ, Reiter A, Roufosse F, Weller PF, Hellmann A, Metzgeroth G, Leiferman KM, Arock M, Sotlar K, Butterfield JH, Cerny-Reiterer S, Mayerhofer M, Vandenberghe P, Haferlach T, Bochner BS, Gotlib J, Horny HP, Simon HU, Klion AD. Valent P, et al. Expert Rev Hematol. 2012 Apr;5(2):157-76. doi: 10.1586/ehm.11.81. Expert Rev Hematol. 2012. PMID: 22475285 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical